← Back to catalogue

Matrix for use with MALDI-TOF MS

EUDAMED

Class A (EU MDR)

Ref 2701200015Model Type II: 600 tests/boxRef 2701200017Model Type II 2500 tests/box

by Zhuhai DL Biotech Co., Ltd.

Identity

Trade Name
Matrix for use with MALDI-TOF MS EUDAMED
Device Name
Matrix for use with MALDI-TOF MS EUDAMED
Model / Reference
Type II: 600 tests/box EUDAMED
2701200015 EUDAMED
Type II 2500 tests/box EUDAMED
2701200017 EUDAMED

Identifiers

Primary DI / UDI-DI
06971025210719 EUDAMED
06971025210733 EUDAMED
Basic UDI-DI
69710252106961116002MG EUDAMED
69710252107331222003G8 EUDAMED
Direct Marketing DI
06971025210719 EUDAMED
06971025210733 EUDAMED
EMDN Code
W010499 MICROBIOLOGY TESTS - OTHER EUDAMED

Classification

Device Class
Class A EUDAMED
Market of Registration
Spain EUDAMED
Romania EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

The Matrix for use with MALDI-TOF MS device is a laboratory instrument designed for protein detection and analysis. It uses matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) to identify and quantify proteins in biological samples. This device provides accurate and reliable results, making it an essential tool for researchers, clinicians, and scientists.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000036485
Authorised Representative
Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001

Sources (2)

  • EUDAMED d78e381f-d7d2-42b2-b011-0a2d3affdb0e 61 fields · synced Sep 17, 2026
  • EUDAMED 39e56823-a0bc-4b74-b9b4-e7ba7e757869 61 fields · synced May 18, 2026